Indication
Cardiogenic shock
Cardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume. Read more about Cardiogenic shock
20 drugs 9 manufacturers
Drugs that treat it
Common Cardiogenic shock therapies.
DOBUTAMINE HCL IN DEXTROSE (dobutamine HCl in dextrose 5 % in water)
DOPAMINE HCL IN 5% DEXTROSE (dopamine HCl in dextrose 5 % in water)
DOPAMINE HCL IN 5% DEXTROSE (dopamine HCl in dextrose 5 % in water)
DOBUTAMINE HCL IN DEXTROSE (dobutamine HCl in dextrose 5 % in water)
DOBUTAMINE HCL
DOBUTAMINE HCL
DOPAMINE HCL
DOPAMINE HCL IN 5% DEXTROSE (dopamine HCl in dextrose 5 % in water)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume.
Most commonly triggered by acute myocardial infarction, it can also stem from severe cardiomyopathies, valvular disruption, mechanical complications, or intractable arrhythmias.
Pathophysiologically, sustained myocardial dysfunction initiates a vicious cycle of persistent hypotension, increased ventricular filling pressures, systemic vasoconstriction, and impaired coronary perfusion.
Clinically, it manifests as profound arterial hypotension, altered mental status, cold extremities, oliguria, elevated serum lactate, and progressive multiorgan dysfunction.
- nih.gov
Cardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume Most commonly triggered by acute myocardial infarction, it can also stem from severe cardiomyopathies, valvular disruption, mechanical complications, or intractable arrhythmias Clinically, it manifests as profound arterial hypotension, alter...
- nih.gov
Cardiogenic shock is a critical, life-threatening cardiovascular syndrome characterized by primary cardiac pump failure that leads to severely reduced cardiac output, systemic hypoperfusion, and widespread tissue hypoxia despite adequate intravascular volume Most commonly triggered by acute myocardial infarction, it can also stem from severe cardiomyopathies, valvular disruption, mechanical complications, or intractable arrhythmias
- nih.gov
Pathophysiologically, sustained myocardial dysfunction initiates a vicious cycle of persistent hypotension, increased ventricular filling pressures, systemic vasoconstriction, and impaired coronary perfusion
- nih.gov
Pathophysiologically, sustained myocardial dysfunction initiates a vicious cycle of persistent hypotension, increased ventricular filling pressures, systemic vasoconstriction, and impaired coronary perfusion
- nih.gov
Clinically, it manifests as profound arterial hypotension, altered mental status, cold extremities, oliguria, elevated serum lactate, and progressive multiorgan dysfunction
Personalize your experience
Follow Cardiogenic shock and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.